SS Innovations expands board to 7, appoints Dr. Frederic Moll (Intuitive Surgical co-founder) and Timothy Adams

SS Innovations International, Inc.

Board expanded from 5 to 7 members; Dr. Frederic Moll appointed as director and non-executive Vice Chairman, effective August 20, 2024.
Dr. Moll co-founded Intuitive Surgical and Auris Health; most recently Chief Development Officer at Johnson & Johnson Medical Devices (2019-2023).
Timothy P. Adams appointed as director; current Regional Operating Officer at Ascension, overseeing high-growth horizontal business units.
Both appointees deemed independent; compensation committee formed with Adams (Chair), Moll, and Dr. S.P. Somashekhar.
Company cites their expertise in robotic surgery and U.S. healthcare as key to advancing FDA approval and market expansion.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Timothy P. Adams

Director

SSII · SS Innovations International, Inc.

Effective: 2024-08-20
Filed: August 22, 2024, 7:59 PM ET

Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board.

Appointed

Dr. Frederic Moll

Director and Non-executive Vice Chairman

SSII · SS Innovations International, Inc.

Effective: 2024-08-20
Filed: August 22, 2024, 7:59 PM ET

Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board. In addition, Dr. Moll was appointed as non-executive Vice Chairman of the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy P. Adams was appointed as Director at SS Innovations International, Inc..

Action: appointed
Role: Director

Exact text from the filing

Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Frederic Moll was appointed as Director and Non-executive Vice Chairman at SS Innovations International, Inc..

Action: appointed
Role: Director and Non-executive Vice Chairman

Exact text from the filing

Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board. In addition, Dr. Moll was appointed as non-executive Vice Chairman of the Board of Directors.

View on SEC.gov

SS Innovations International, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-071833

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.